SKI Market

A+| A| A-|

Indian Indices

Sensex

73,918.76 394.50
( 0.54%)

Global Indices

Nasdaq

50,812.84 -74.94
(-0.15%)

Dow Jones

7,426.81 22.07
(0.30%)

Hang Seng

65,160.26 1,135.66
(1.77%)

Nikkei 225

10,242.24 -130.96
(-1.26%)

Forex

USD-INR

95.22 -0.51
(-0.53%)

EUR-INR

109.67 -1.54
(-1.39%)

GBP-INR

126.98 -1.60
(-1.25%)

JPY-INR

0.59 0.00
(-0.77%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Lupin Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500257

INE326A01037

659.0470742

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

LUPIN

17.08

102996.2

EPS(TTM)

Face Value()

Div & Yield %

131.91

0.8

Back

Nuvama Wealth Management consolidated net profit rises 0.67% in the December 2025 quarter

Jan 24,2026

Net profit of Nuvama Wealth Management rose 0.67% to Rs 253.80 crore in the quarter ended December 2025 as against Rs 252.10 crore during the previous quarter ended December 2024. Sales rose 6.75% to Rs 1104.19 crore in the quarter ended December 2025 as against Rs 1034.35 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	1104.19	1034.35	7
OPM %	54.99	56.24	-
PBDT	366.62	358.12	2
PBT	339.98	334.08	2
NP	253.80	252.10	1

73,918.76 394.50 ( 0.54%)

50,812.84 -74.94 (-0.15%)

7,426.81 22.07 (0.30%)

65,160.26 1,135.66 (1.77%)

10,242.24 -130.96 (-1.26%)

95.22 -0.51 (-0.53%)

109.67 -1.54 (-1.39%)

126.98 -1.60 (-1.25%)

0.59 0.00 (-0.77%)